1-7 of 7
Janice M Hodnefield, MS, MT(ASCP)
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phenotypic and Prognostic Correlates of Spliceosome Mutations ( SRSF2 , SF3B1 , U2AF35 ) in Chronic Myelomonocytic Leukemia with ≥ 1% Ring Sideroblasts.

Mrinal M. Patnaik, MBBS, MD, Terra L Lasho, MT, (ASCP), Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2012) 120 (21): 2803.
https://doi.org/10.1182/blood.V120.21.2803.2803
Published: 2012
Journal Articles

Survival and Prognosis in World Health Organization Defined Chronic Myelomonocytic Leukemia- A Mayo Clinic Series of 227 Patients

Mrinal M. Patnaik, MBBS, MD, Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2012) 120 (21): 3790.
https://doi.org/10.1182/blood.V120.21.3790.3790
Published: 2012
Journal Articles

Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)

Naseema Gangat, MD, Mrinal M. Patnaik, MBBS, MD, Kebede Begna, MD, Taxiarchis Kourelius, MD, Ryan A Knudson, Rhett P Ketterling, MD, Janice M Hodnefield, MS, MT(ASCP), Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2012) 120 (21): 423.
https://doi.org/10.1182/blood.V120.21.423.423
Published: 2012
Journal Articles

Spliceosome Mutations Involving SRSF2 , SF3B1 and U2AF35 in World Health Organization Defined Chronic Myelomonocytic Leukemia; Prevalence, Clinical Correlates and Prognosis

Mrinal M. Patnaik, MBBS, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Curtis A Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2012) 120 (21): 1711.
https://doi.org/10.1182/blood.V120.21.1711.1711
Published: 2012
Journal Articles

SF3B1 Mutations Are Prevalent in Myelodysplastic Syndromes with Ring Sideroblasts but Do Not Hold Independent Prognostic Value

Mrinal M. Patnaik, MBBS, MD, Terra L Lasho, MT, (ASCP), Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Aref Al-Kali, MD, Guillermo Garcia-Manero, David P. Steensma, MD, Animesh Pardanani, MBBS, PhD, Curtis A Hanson, Ayalew Tefferi, MD
Journal: Blood
Blood (2011) 118 (21): 460.
https://doi.org/10.1182/blood.V118.21.460.460
Published: 2011
Journal Articles

Differential Prognostic Effect of IDH1 Versus IDH2 Mutations in Myelodysplastic Syndromes: A Mayo Clinic Study of 277 Patients

Mrinal M. Patnaik, MBBS, MD, Curtis A. Hanson, MD, Janice M Hodnefield, MS, MT(ASCP), Terra L Lasho, MT, (ASCP), Christy Finke, BS, Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD
Journal: Blood
Blood (2011) 118 (21): 971.
https://doi.org/10.1182/blood.V118.21.971.971
Published: 2011
Journal Articles

Prognostic Irrelevance of Ring Sideroblast Percentage in World Health Organization Defined Myelodysplastic Syndromes without Excess Blasts,

Mrinal M. Patnaik, MBBS, MD, Curtis A Hanson, Nanna Sulai, Janice M Hodnefield, MS, MT(ASCP), Ryan A Knudson, Rhett P Ketterling, MD, Terra L Lasho, MT, (ASCP), Ayalew Tefferi, MD
Journal: Blood
Blood (2011) 118 (21): 3803.
https://doi.org/10.1182/blood.V118.21.3803.3803
Published: 2011